科研速递论坛

标题: Efficacy and safety of third-line treatment with anlotinib in patients with r... [打印本页]

作者: bqcool 时间: 2018-8-3 12:52
标题: Efficacy and safety of third-line treatment with anlotinib in patients with r...

题名	Efficacy and safety of third-line treatment with anlotinib in patients with refractory advanced non-small-cell lung cancer (ALTER-0303): a randomised, double-blind, placebo-controlled phase 3 study
链接	https://www.sciencedirect.com/science/article/pii/S1470204517307593

作者: dpzc11 时间: 2018-8-3 12:52
http://disk.680.com/3InMfa

欢迎光临科研速递论坛 (http://www.expaper.cn/)